Cargando…

Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a complex multifactorial degenerative disease that leads to irreversible blindness. AMD affects the macula, the central part of the retina responsible for sharp central vision. Retinal pigment epithelium (RPE) is the main cellular type affected in dry AMD. R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baiula, Monica, Caligiana, Alberto, Bedini, Andrea, Zhao, Junwei, Santino, Federica, Cirillo, Martina, Gentilucci, Luca, Giacomini, Daria, Spampinato, Santi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878375/ https://www.ncbi.nlm.nih.gov/pubmed/33584300 http://dx.doi.org/10.3389/fphar.2020.617836

Ejemplares similares

Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α(4)β(1) Integrin
por: Baiula, Monica, et al.
Publicado: (2023)

Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials
por: Anselmi, Michele, et al.
Publicado: (2021)

Novel Ligands Targeting α(4)β(1) Integrin: Therapeutic Applications and Perspectives
por: Baiula, Monica, et al.
Publicado: (2019)

Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials
por: Zhao, Junwei, et al.
Publicado: (2020)

Selective Integrin Ligands Promote Cell Internalization of the Antineoplastic Agent Fluorouracil
por: Baiula, Monica, et al.
Publicado: (2021)

Integrin-mediated adhesive properties of neutrophils are reduced by hyperbaric oxygen therapy in patients with chronic non-healing wound
por: Baiula, Monica, et al.
Publicado: (2020)

Design and Pharmacological Characterization of α(4)β(1) Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism
por: Anselmi, Michele, et al.
Publicado: (2023)

Experimental Pharmacotherapy for Dry Eye Disease: A Review
por: Baiula, Monica, et al.
Publicado: (2021)

Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics
por: Bedini, Andrea, et al.
Publicado: (2022)

Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
por: Tolomelli, Alessandra, et al.
Publicado: (2017)

Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist
por: Bedini, Andrea, et al.
Publicado: (2020)

Therapeutic Targeting of Eosinophil Adhesion and Accumulation in Allergic Conjunctivitis
por: Baiula, Monica, et al.
Publicado: (2012)

Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy
por: Baiula, Monica, et al.
Publicado: (2014)

Molecular Delivery of Cytotoxic Agents via Integrin Activation
por: Cirillo, Martina, et al.
Publicado: (2021)

Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
por: Baiula, Monica, et al.
Publicado: (2011)

Side chain effect in the modulation of α(v)β(3)/α(5)β(1) integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems
por: Ferrazzano, Lucia, et al.
Publicado: (2020)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin, Laurie, et al.
Publicado: (2015)

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2016)

Recent developments in the management of dry age-related macular degeneration
por: Buschini, Elisa, et al.
Publicado: (2015)

Update on Clinical Trials in Dry Age-related Macular Degeneration
por: Taskintuna, Ibrahim, et al.
Publicado: (2016)

The Use of Fundus Autofluorescence in Dry Age-Related Macular Degeneration
por: Şahinoğlu Keşkek, Nedime, et al.
Publicado: (2021)

Emerging options for the management of age-related macular degeneration with stem cells
por: Mooney, Ingrid, et al.
Publicado: (2010)

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration
por: Kersten, Eveline, et al.
Publicado: (2018)

Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
por: Ozyurt, Ayhan, et al.
Publicado: (2017)

Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye
por: Hobbs, Ronald P., et al.
Publicado: (2014)

AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration
por: Jang, Ki-Hong, et al.
Publicado: (2017)

The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration
por: Schultz, Neil M., et al.
Publicado: (2021)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
por: Patel, Prem N., et al.
Publicado: (2022)

Serum Autoantibodies in Patients with Dry and Wet Age-Related Macular Degeneration
por: Korb, Christina A., et al.
Publicado: (2023)

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
por: Qin, Shuqi, et al.
Publicado: (2021)

Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options
por: Fernandes, Ana Rita, et al.
Publicado: (2022)

Analysing the Progression Rates of Macular Lesions with Autofluorescence Imaging Modes in Dry Age-Related Macular Degeneration
por: Olcay, Kenan, et al.
Publicado: (2015)

Experiences with the Scharioth Macula Lens – new hope for patients with dry macular degeneration
por: Bereczki, Árpád
Publicado: (2019)

Recent advances in the management of dry age-related macular degeneration: A review
por: Bandello, Francesco, et al.
Publicado: (2017)

Choroidal Vascularity Index in Different Cohorts of Dry Age-Related Macular Degeneration
por: Sacconi, Riccardo, et al.
Publicado: (2021)

Classification of dry and wet macular degeneration based on the ConvNeXT model
por: Wu, Maonian, et al.
Publicado: (2022)

Investigating the Spatiotemporal Summation of Perimetric Stimuli in Dry Age-Related Macular Degeneration
por: Hunter, Aoife M. L., et al.
Publicado: (2023)

Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
por: Santino, Federica, et al.
Publicado: (2023)

Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular Degeneration
por: De Bruyne, Sander, et al.
Publicado: (2020)

Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l5go5a2d4gu6trsf7io16uoam9